Gangarosa E J, Galazka A M, Wolfe C R, Phillips L M, Gangarosa R E, Miller E, Chen R T
Gangarosa International Health Foundation and Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Lancet. 1998 Jan 31;351(9099):356-61. doi: 10.1016/s0140-6736(97)04334-1.
To assess the impact of anti-vaccine movements that targeted pertussis whole-cell vaccines, we compared pertussis incidence in countries where high coverage with diphtheria-tetanus-pertussis vaccines (DTP) was maintained (Hungary, the former East Germany, Poland, and the USA) with countries where immunisation was disrupted by anti-vaccine movements (Sweden, Japan, UK, The Russian Federation, Ireland, Italy, the former West Germany, and Australia). Pertussis incidence was 10 to 100 times lower in countries where high vaccine coverage was maintained than in countries where immunisation programs were compromised by anti-vaccine movements. Comparisons of neighbouring countries with high and low vaccine coverage further underscore the efficacy of these vaccines. Given the safety and cost-effectiveness of whole-cell pertussis vaccines, our study shows that, far from being obsolete, these vaccines continue to have an important role in global immunisation.
为评估针对百日咳全细胞疫苗的反疫苗运动的影响,我们比较了白喉-破伤风-百日咳疫苗(DTP)高覆盖率国家(匈牙利、前东德、波兰和美国)与免疫接种因反疫苗运动而中断的国家(瑞典、日本、英国、俄罗斯联邦、爱尔兰、意大利、前西德和澳大利亚)的百日咳发病率。疫苗高覆盖率国家的百日咳发病率比免疫接种计划因反疫苗运动而受到影响的国家低10至100倍。对疫苗覆盖率高和低的邻国进行比较,进一步凸显了这些疫苗的有效性。鉴于全细胞百日咳疫苗的安全性和成本效益,我们的研究表明,这些疫苗远未过时,在全球免疫接种中继续发挥着重要作用。